Study of the effect of Anagliptin administration on the activity of glucagon after test meal loading

Trial Profile

Study of the effect of Anagliptin administration on the activity of glucagon after test meal loading

Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Anagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Jul 2017 According to UMIN, the date for data entry closure is 2018/02/28 , and the date for conclusion of data analysis is 2018/04/30.
    • 13 Jul 2017 Planned End Date changed from 31 Jul 2017 to 31 Jan 2018.
    • 10 Nov 2016 Planned End Date changed from 31 Dec 2016 to 31 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top